YIH
DNA icon

Y-Intercept (HK)’s Ginkgo Bioworks DNA Stock Holding History

Y-Intercept (HK)’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,678
Closed -$154K – 1290
2024
Q4 		$154K Buy
+15,678
New +$134K 0.01% 1074
2024
Q3 		– Sell
-25,288
Closed -$338K – 1423
2024
Q2 		$338K Buy
25,288
+19,596
+344% +$585K 0.02% 984
2024
Q1 		$264K Buy
+5,692
New +$295K 0.02% 1015
2023
Q2 		– Sell
-939
Closed -$50K – 1363
2023
Q1 		$50K Buy
+939
New +$59.5K 0.01% 1101

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $758M AUM 124.8% 1-Year Est. Return